MEANINGFUL CHANGE IN PEYRONIE'S DISEASE FOLLOWING TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM: RESULTS FROM TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES

被引：5
|
作者：
Hellstrom, Wayne J. G.
Gittleman, Marc
Tan, Ronny B. W.
Tursi, James P.
Smith, Ted
Kaufman, Gregory J.
Jones, Nigel A.
Carson, Culley C.
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.1853
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD22-02
引用
收藏
页码：E672 / E672
页数：1
相关论文
共 50 条
  • [21] Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite)
    Goldman, Mitchel P.
    Sadick, Neil S.
    Young, Leroy
    Kaufman, Gregory J.
    Smith, Ted
    Tursi, James P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB19 - AB19
  • [22] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
    Hayden, Frederick G.
    Lenk, Robert P.
    Stonis, Lucille
    Oldham-Creamer, Catherine
    Kang, Lih Lisa
    Epstein, Carol
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
  • [23] Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study
    Safarinejad, MR
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (03) : 238 - 243
  • [24] Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study
    M R Safarinejad
    International Journal of Impotence Research, 2004, 16 : 238 - 243
  • [25] BRIVARACETAM IN PATIENTS WITH UNVERRICHT-LUNDBORG DISEASE: RESULTS FROM TWO RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDIES
    Kalviaiinen, R.
    Genton, P.
    Andermann, E.
    Magaudda, A.
    Frucht, S.
    Schlit, A.
    Gerard, D.
    Van Otterdijk, E.
    von Rosenstiel, P.
    EPILEPSIA, 2009, 50 : 47 - 47
  • [26] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [27] BASELINE CHARACTERISTICS FROM A PHASE 3 STUDY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN PATIENTS WITH PEYRONIE'S DISEASE
    Goldstein, Irwin
    McMahon, Chris
    White, Charles
    Smith, Ted
    Kaufman, Greg
    Tursi, James
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 52 - 52
  • [28] Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies
    Vinik, Aaron I.
    Tuchman, Michael
    Safirstein, Beth
    Corder, Clinton
    Kirby, Louis
    Wilks, Kerri
    Quessy, Steve
    Blum, David
    Grainger, Joanne
    White, Jonathan
    Silver, Marianne
    PAIN, 2007, 128 (1-2) : 169 - 179
  • [29] Incremental Treatment Response by Cycle With Collagenase Clostridium Histolyticum for Peyronie's Disease: A Pooled Analysis of Two Phase 3 Trials
    Ziegelmann, Matthew
    Hu, Yiqun
    Xiang, Qinfang
    Liu, Genzhou
    McLane, Michael P.
    Trost, Landon
    UROLOGY, 2023, 175 : 126 - 131
  • [30] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
12345